Could a Validated Biomarker Transform the Lupus Market?Decision ResourcesDecember 19, 2006 21 Pages - SKU: DECR1399798 |
|
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 5th Edition
5/11/2012 | published by: Kalorama Information
The drug discovery process is long, arduous and costly, which has driven outsourcing in this field. The first phase is discovery of a lead compound, a molecule that affects biological function by binding to a
|
more...
|
$3,995.00
|
|
Emergency Contraception in Latvia
5/8/2012 | published by: Euromonitor International
Emergency contraception witnessed sales growth in 2011. The government was not successful in improving the birth rate, which could have affected development of emergency contraception in 2011. The birth rate remained stable and total population
|
more...
|
$900.00
|
|
Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019
5/21/2012 | published by: GlobalData
Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Summary GlobalData, the industry analysis specialist, has released its new report, “Retinal Vein Occlusion Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report
|
more...
|
$3,995.00
|
|
World Market for Personalized Medicine Diagnostics (Biomarkers, Pharmacodiagnostics, Tumor Assays, Cardiac Risk and Other Testing)
3/1/2012 | published by: Kalorama Information
In this market research report, Kalorama Information defines the current opportunity and a realistic future potential for personalized medicine in clinical testing. In addition to analysis of tests currently on the market and in development,
|
more...
|
$3,795.00
|
|
Hemorrhoids Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Hemorrhoids Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Hemorrhoids Global Clinical Trials Review, H1, 2012 provides data on the Hemorrhoids clinical trial scenario. This report provides elemental information and data relating to the
|
more...
|
$1,000.00
|
|
Hepatic Encephalopathy Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Hepatic Encephalopathy Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Hepatic Encephalopathy Global Clinical Trials Review, H1, 2012 provides data on the Hepatic Encephalopathy clinical trial scenario. This report provides elemental information and data
|
more...
|
$1,000.00
|
|
Hepatic Injury Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Hepatic Injury Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Hepatic Injury Global Clinical Trials Review, H1, 2012 provides data on the Hepatic Injury clinical trial scenario. This report provides elemental information and data
|
more...
|
$1,000.00
|
|
Hepatic Insufficiency Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Hepatic Insufficiency Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Hepatic Insufficiency Global Clinical Trials Review, H1, 2012 provides data on the Hepatic Insufficiency clinical trial scenario. This report provides elemental information and data
|
more...
|
$1,000.00
|
|
Commercializing Biomarkers in Therapeutic and Diagnostic Applications
5/1/2012 | published by: CHI Insight Pharma Reports
Biomarkers feature in thousands of published articles each year, evidencing the high level of interest and research in this field. This report focuses on issues that must be addressed to utilize this growing knowledge about
|
more...
|
$3,195.00
|
|
Lung Injury Global Clinical Trials Review, H1, 2012
4/25/2012 | published by: GlobalData
Lung Injury Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Lung Injury Global Clinical Trials Review, H1, 2012 provides data on the Lung Injury clinical trial scenario. This report provides elemental information and data
|
more...
|
$1,000.00
|
Related Markets
- Biotechnology
- Biomarkers
- Diseases & Conditions
- Autoimmune
- Pharmaceuticals
- Drug Discovery
- Therapeutic Area
- Women's Health
Women's Health Reports
- Triple Analysis: Breast Cancer, Pancreatic Cancer and Protein Kinase Inhibitors
- Triple Analysis: Breast Cancer, Melanoma and Protein Kinase Inhibitors
- Triple Analysis: Breast Cancer, Lymphoma and Protein Kinase Inhibitors
- Triple Analysis: Breast Cancer, Lung Cancer and Protein Kinase Inhibitors
- Triple Analysis: Breast Cancer, Leukemia and Protein Kinase Inhibitors
